Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
146,614,676
-
Total 13F shares
-
123,500,078
-
Share change
-
-214,480
-
Total reported value
-
$29,628,123,955
-
Put/Call ratio
-
158%
-
Price per share
-
$239.92
-
Number of holders
-
996
-
Value change
-
-$101,746,917
-
Number of buys
-
360
-
Number of sells
-
541
Institutional Holders of BIOGEN INC. - COM (BIIB) as of Q4 2021
As of 31 Dec 2021,
BIOGEN INC. - COM (BIIB) was held by
996 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
123,500,078 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, Clearbridge Investments, LLC, NORTHERN TRUST CORP, and DEUTSCHE BANK AG\.
This page lists
998
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.